Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/25/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Gerald Migliaccio?

Gerald P. Migliaccio

Vice President, Quality

EHS

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

EHS

Background Information

Employment History

Head

Expert Working Group


Vice President

Quality


Staff Chemist In Quality Control

Terre Haute


Affiliations

Middlesex Hospital

Board Member


Council for Chemical Research Inc

Governing Board Member


PhRMA GMP Steering

Member of Committee


Education

Bachelor's degree

Chemistry

Holy Cross College


M.S.

Medicinal Chemistry

Purdue University.


Web References(59 Total References)


Who's Responsible for Global Supply Chain Security? - RxTrace

www.rxtrace.com [cached]

Adam Fein, Daniel Matlis, DrugChannels, FDA, FDA budget, Gerald Migliaccio, Pfizer, PharmaTech, PharmTechTalk, standards, supply chain security
It's an interesting question and Matlis juxtaposes the FDA paper against comments reportedly made by Gerald Migliaccio, Vice President of Quality, EHS and Agility at Pfizer Global Manufacturing at a recent joint session of the PharmTech Conference and the Manufacturing Execution System in Life-Sciences Congress. Migliaccio believes that, "Supply chain security is the responsibility of all parties involved in procurement/ sourcing, manufacturing, packaging and distribution of raw materials, intermediates and final product."


2009 September

www.rxtrace.com [cached]

It's an interesting question and Matlis juxtaposes the FDA paper against comments reportedly made by Gerald Migliaccio, Vice President of Quality, EHS and Agility at Pfizer Global Manufacturing at a recent joint session of the PharmTech Conference and the Manufacturing Execution System in Life-Sciences Congress.
Migliaccio believes that, "Supply chain security is the responsibility of all parties involved in procurement/ sourcing, manufacturing, packaging and distribution of raw materials, intermediates and final product." Posted in Adam Fein, Daniel Matlis, DrugChannels, FDA, FDA budget, Gerald Migliaccio, Pfizer, PharmaTech, PharmTechTalk, standards, supply chain security | Tags: Adam Fein, Daniel Matlis, DrugChannels, FDA, FDA budget, Gerald Migliaccio, Pfizer, PharmaTech, PharmTechTalk, standards, supply chain security |


Who’s Responsible for Global Supply Chain Security?

www.rxtrace.com [cached]

It's an interesting question and Matlis juxtaposes the FDA paper against comments reportedly made by Gerald Migliaccio, Vice President of Quality, EHS and Agility at Pfizer Global Manufacturing at a recent joint session of the PharmTech Conference and the Manufacturing Execution System in Life-Sciences Congress.
Migliaccio believes that, "Supply chain security is the responsibility of all parties involved in procurement/ sourcing, manufacturing, packaging and distribution of raw materials, intermediates and final product." Posted in Adam Fein, Daniel Matlis, DrugChannels, FDA, FDA budget, Gerald Migliaccio, Pfizer, PharmaTech, PharmTechTalk, standards, supply chain security | Tags: Adam Fein, Daniel Matlis, DrugChannels, FDA, FDA budget, Gerald Migliaccio, Pfizer, PharmaTech, PharmTechTalk, standards, supply chain security


axendia

bioitalliance.org [cached]

Securing the Global Supply Chain, FDA's or Industry's Responsibility? In my opening remarks at the 4th Annual Manufacturing Execution System in Life-Sciences Conference, I discussed FDA's proposed budget increase of 166 Million Dollars and 346 FTEs toward Medical Product Supply Chain Safety and Security Oversight.  At the Conference, Gerald Migliaccio, Pfizer's Vice President of Quality, EHS and Agility -provided his company's perspective on Supply Chain Security.  "Supply chain security is the responsibility of all parties involved in procurement, sourcing, manufacturing, packaging and distribution of raw materials, intermediates and final product," commented Mr. Migliaccio.
"Ultimately, the marketing authorization holder(industry) is responsible for assuring that all parties in the supply chain fulfill their responsibilities for delivering safe and effective medicines to customers" he added.  To learn more details about new approaches Pfizer and FDA are proposing to ensure Global Supply Chain Safety, read the complete article in Life-Science Panorama:  http://axendia.com/blog/2009/08/26/pfizer-fda-on-supply-chain-security/ axendia http://bioitalliance.org/members/axendia.aspx


Life-Science Panorama - A Journal for Industry Executives » Pfizer and FDA Share Perspectives on Supply Chain Security

axendia.com [cached]

In his Keynote, Gerald Migliaccio, Pfizer's Vice President of Quality, EHS and Agility - Pfizer Global Manufacturing, addressed Supply Chain Security from an industry perspective.
"Supply chain security is the responsibility of all parties involved in procurement, sourcing, manufacturing, packaging and distribution of raw materials, intermediates and final product," commented Mr. Migliaccio. "Ultimately, the marketing authorization holder(industry) is responsible for assuring that all parties in the supply chain fulfill their responsibilities for delivering safe and effective medicines to customers" he added. According to Mr. Migliaccio, strong supply chain security strategies benefits both patients and industry by: In Gerry Migliaccio's words "while we have been very successful at advancing science and risk-based approaches to quality, all of our efforts can be rendered moot if we cannot secure the supply chain."


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory